Sarcoidosis is a systemic granulomatous disease of unknown etiology that primarily affects
the lungs. The etiology remains unclear; however, environmental, genetic, ethnic, and …

Sarcoidosis is a systemic disease of unknown etiology characterized by the presence of
noncaseating granulomas that can occur in any organ, most commonly the lungs. Early and …

Sarcoidosis is an immune-mediated disorder. Its immunopathology has been steadily
mapped out over the past few decades. Despite this, the underpinning mechanisms for …

Sarcoidosis is a chronic granulomatous disease of unknown etiology that primarily affects
the lungs. The development of stage IV or fibrotic lung disease accounts for a significant …

Sarcoidosis is a disorder of unknown etiology. It is a systemic disease, frequently involving
the lungs, skin, eyes, and lymph nodes. It is characterized by formation of noncaseating …

Sarcoidosis is a systemic granulomatous disease of undetermined etiology invariably
affecting the lungs and thoracic lymph nodes. It has been termed an “immune paradox”, as …

AIMS: Sarcoidosis is a granulomatous disease of unknown etiology marked by tremendous
clinical heterogeneity. Many patients enter remission with good long-term outcomes. Yet …

Sarcoidosis is a multisystem disease with tremendous heterogeneity in disease
manifestations, severity, and clinical course that varies among different ethnic and racial …

It is well-recognized that sarcoidosis is a multisystemic disorder of unknown etiology that can
present with a myriad of signs and symptoms, but most commonly presents with pulmonary …

Sarcoidosis is a chronic granulomatous disorder characterized by an accumulation of T
lymphocytes, macrophages, and immune-effector cells within affected organs. The …